Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Danielczyk

Showing results (61-70 of 67) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 67 results.
Wiener Medizinische Wochenschrift (1946)|January 1, 1991
[Alzheimer dementia. A clinical long-term study with quantitative neuropathology]P Fischer, H Lassmann, K Jellinger, et al.
Neuroscience|January 1, 1992
Synaptic pathology in Alzheimer's disease: immunological data for markers of synaptic and large dense-core vesiclesH Lassmann, R Weiler, P Fischer, et al.
The Mount Sinai Journal of Medicine, New York|January 1, 1988
Biochemical fundamentals of Parkinson's diseaseP Riederer, W D Rausch, B Schmidt, et al.
European Journal of Clinical Pharmacology|January 1, 1992
Bromocriptine lessens the incidence of mortality in L-dopa-treated parkinsonian patients: prado-study discontinuedH Przuntek, D Welzel, E Blümner, et al.
Neuroscience Letters|June 16, 2000
Human post-mortem striatal alpha4beta2 nicotinic acetylcholine receptor density in schizophrenia and Parkinson's syndromeN Durany, R Zöchling, K W Boissl, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|January 1, 1996
Early institution of bromocriptine in Parkinson's disease inhibits the emergence of levodopa-associated motor side effects. Long-term results of the PRADO studyH Przuntek, D Welzel, M Gerlach, et al.
Neurobiology of Aging|January 18, 2005
Oxidative stress related markers in the "VITA" and the centenarian projectsE Grünblatt, R Schlösser, P Fischer, et al.
Pageof 7

Showing results (61-70 of 67) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 67 results.
Wiener Medizinische Wochenschrift (1946)|January 1, 1991
[Alzheimer dementia. A clinical long-term study with quantitative neuropathology]P Fischer, H Lassmann, K Jellinger, et al.
Neuroscience|January 1, 1992
Synaptic pathology in Alzheimer's disease: immunological data for markers of synaptic and large dense-core vesiclesH Lassmann, R Weiler, P Fischer, et al.
The Mount Sinai Journal of Medicine, New York|January 1, 1988
Biochemical fundamentals of Parkinson's diseaseP Riederer, W D Rausch, B Schmidt, et al.
European Journal of Clinical Pharmacology|January 1, 1992
Bromocriptine lessens the incidence of mortality in L-dopa-treated parkinsonian patients: prado-study discontinuedH Przuntek, D Welzel, E Blümner, et al.
Neuroscience Letters|June 16, 2000
Human post-mortem striatal alpha4beta2 nicotinic acetylcholine receptor density in schizophrenia and Parkinson's syndromeN Durany, R Zöchling, K W Boissl, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|January 1, 1996
Early institution of bromocriptine in Parkinson's disease inhibits the emergence of levodopa-associated motor side effects. Long-term results of the PRADO studyH Przuntek, D Welzel, M Gerlach, et al.
Neurobiology of Aging|January 18, 2005
Oxidative stress related markers in the "VITA" and the centenarian projectsE Grünblatt, R Schlösser, P Fischer, et al.
Pageof 7